arrow
S

Silvia Beatriz Boscardin

University of São Paulo
H指数:28
被引数:2,975

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multi-antigen chimeric PvCSP–MSP119 vaccine induces robust humoral responses against distinct stages of Plasmodium vivax

多抗原嵌合 PvCSP–MSP1<sub>19</sub> 疫苗诱导针对不同阶段的 <em>Plasmodium vivax</em> 的强效体液免疫反应

Vaccine
IF3.5
2026-10-020
PRE
An mRNA–lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen

靶向<em>Plasmodium vivax</em> E140抗原的mRNA-脂质纳米颗粒疫苗

2026-09-020
OAAI
Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice

AddaS03和聚I:C佐剂对BALB/c小鼠RBD疫苗接种后抗体滴度和Th1偏向T细胞反应的协同效应

Vaccine
IF3.5
2026-08-220
OA
An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication

一种针对SARS-CoV-2的创新性鼻用纳米疫苗可诱导系统性及上呼吸道免疫,控制病毒复制

2026-03-040
OAAI
Molecular Characterization of Calu-3 Cells from Submerged to Air–Liquid Interface to Model Lung Infections
2026-01-280
OA
Electrochemical Detection of SARS-CoV-2 in Saliva Using ZnO Nanorods Functionalized with Gold-Conjugated Antireceptor-Binding Domain Antibodies

利用与抗受体结合域抗体金标记的ZnO纳米棒电化学检测唾液中的SARS-CoV-2

2025-10-280
OAAI
Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants

小鼠抗体4B1D3对SARS-CoV-2变种表现出广泛的交叉反应性和中和活性。

2025-07-210
PRE
Neutralizing antibody responses after a two-dose regimen with BNT162b2 CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants

巴西使用BNT162b2、CoronaVac或ChAdOx1-S两剂接种方案后的中和抗体反应:对SARS-CoV-2奥密克戎变异株的中和差异

2025-07-010
PRE
P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity

P.1和P.2 SARS-CoV-2巴西变异株激活了具有时间和通路特异性的未折叠蛋白反应

2025-05-010
PRE
Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein

重组rbd-igg嵌合蛋白预防接种后增强的免疫原性和对SARS-CoV-2的保护作用

2024-03-271
OAAI
Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells

细菌和昆虫细胞中产生的寨卡病毒包膜蛋白 (E) 衍生物的诊断和疫苗潜力

2023-03-165
OAAI
Protein Arginylation Is Regulated during SARS-CoV-2 Infection
2023-01-194
OAAI
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
2023-01-058
OAAI
The oldest unvaccinated Covid-19 survivors in South America (vol 19, 57, 2022)
2022-12-072
OAAI
The oldest unvaccinated Covid-19 survivors in South America
2022-11-169
OAAI